Martin Shkreli fails to overturn lifetime pharma ban — again; Daiichi Sankyo and ViGeneron re-up eye disease deal

Mar­tin Shkre­li has once again been un­able to con­vince a judge to over­turn his life­time phar­ma in­dus­try ban.
Shkre­li had at­tempt­ed to put the ban on hold while he ap­pealed a 2020 con­vic­tion re­gard­ing his ac­tiv­i­ties re­lat­ed to Dara­prim, but judge Denise Cote of the South­ern Dis­trict of New York was not swayed. Cote is the same judge who hand­ed down the orig­i­nal ban in Jan­u­ary and up­held it a few weeks lat­er.
‘Shkre­li con­tends once more that the In­junc­tion is over­broad, puni­tive, and vague,’ Cote wrote in the case.